Cases & Deals

DT Capital invests in China Biologic

Clients DT Capital Partners

Jones Day advised DT Capital Partners in connection with its purchase of $7.5 million of Convertible Notes and Warrants in a private placement by China Biologic Products, Inc., a biopharmaceutical company that engages in the research, development, production, and manufacturing of plasma-based pharmaceutical products in China.